Human complement component C8 Molecular basis of the β-chain polymorphism by Dewald, Georg et al.
L2iii 
LETTERS 
ELSEVIER 
FEBS Letters 340 (1994) 211-215 
FEBS 13728 
Human complement component C8 
Molecular basis of the P-chain polymorphism 
Georg Dewald*, Susanne Hemmer, Markus M. Nijthen 
Institute of Human Genetics, University of Bonn, Wilhelmstr. 31, D-53111 Bonn, Germany 
Received 14 January 1994 
Abstract 
The B-chain of human complement component C8 exhibits a structural genetic polymorphism: using isoelectric focusing two major allotypes can 
be identified (C8B B (‘basic’) and C8B A (‘acidic’)). In the present report we describe a sequence polymorphism of the C8B gene (codon 63: 
AGA+ GGA) and demonstrate that the resulting amino acid substitution (Arg+Gly) consistently differentiates between the two common 
charge variants of the C8/3 chain; the C8B B allotype is characterized by an Arg and the C8B A allotype by a Gly residue in position 63 of the C8/3 
polypeptide chain. 
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1. Introduction 
Complement component C8 plays an important role 
in the formation of the membrane attack complex 
(MAC) of the complement system. The MAC is a high- 
molecular amphiphilic heteropolymer that is assembled 
from five hydrophilic precursor proteins, the terminal 
complement components C5, C6, C7, C8, and C9; upon 
proteolytic cleavage of C5 to C5a and C5b, the sequen- 
tial addition to C5b of C6, C7, C8, and C9 results in the 
formation of the C5b-9 complex, which mediates the 
damage to biological membranes associated with com- 
plement-dependent cytolysis [ 11. 
Human C8 is a plasma glycoprotein with a molecular 
weight of 151,000, consisting of equimolar amounts of 
three nonidentical polypeptide chains: the a-chain 
(M, = 64,000), the p-chain (Mr = 64,000), and the y- 
chain (&& = 22,000); these are arranged asymmetrically 
as a disulfide-linked a-y-dimer that is noncovalently as- 
sociated with the /?-chain [2-4]. Within the process of 
MAC formation it is the p-chain which mediates the 
interaction of C8 with the C5b-7 complex; C9 associates 
through interaction with a C9-specific site on the a-chain 
[4]. The three chains of C8 are encoded by three separate 
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genes: C8A and C8B, the loci coding for C8a and C8/3, 
are closely linked to one another and have been localized 
to chromosome 1~32 [5-71; C8G, the gene encoding the 
y-chain, has been assigned to chromosome 9q [5]. 
Structural polymorphisms as well as genetically deter- 
mined deficiency states have been found for both the a-y 
complex and the B-chain [8-lo]. The polymorphism of 
the CSa-y subunit (= C8A (previously C81) polymor- 
phism) has been studied rather extensively [8,1 l-141. In 
contrast, the genetic variability of the C8/3 chain has been 
investigated to a lesser extent, probably because of meth- 
odological difficulties (discussed in [ 12,131). The p-chain 
polymorphism (= C8B (previously C82) polymorphism) 
was first described by Alper et al. [9] and later studied 
by Rogde and co-workers [11,12]. In addition, data on 
C8fi polymorphism in Japanese has been published in 
abstract form [15]. For the detection of C8p phenotypes 
plasma or serum proteins have been separated by isoelec- 
tric focusing (IEF) in polyacrylamide gels; specific pro- 
tein identification was achieved either with a hemolytic 
overlay containing CS/? deficient serum [9] or by means 
of an immunoblotting procedure [11 ,12,15]. Family stud- 
ies demonstrated that CS/? variants are inherited as au- 
tosomal codominant traits [9,11]. Two major alleles, 
C8B*B (‘basic’) and C8B*A (‘acidic’), and two rare var- 
iants have been identified; allele frequencies of approxi- 
mately 0.95 (C8B*B) and 0.04 (C8B*A) were reported 
for Caucasians and also for Japanese [9,11,15]. 
The #?-chain of human C8 consists of 537 amino acids; 
the complete primary structure was derived independ- 
ently by two groups from the sequence of C8/3 cDNA 
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clones [16,17] (see also EMBL accession nos. X04393, 
M16973). A comparison of the two cDNA sequences 
suggests the presence of either an A or a G in the first 
position of codon 63, corresponding to an arginine to 
glycine substitution. We postulated that such a type of 
amino acid exchange (positively charged 3 neutral) 
could explain the different isoelectric points of the two 
common p-chain allotypes C8B B and C8B A. Using 
polymerase chain reaction (PCR) we established a simple 
method for direct investigation of the nucleotide se- 
quence in codon 63; this method allowed us to demon- 
strate that codon 63 is indeed polymorphic and to exam- 
ine this DNA polymorphism to account for the C8p 
protein polymorphism. 
2. Materials and methods 
2.1 Blood samples 
EDTA anticoagulated venous blood samples were drawn from 82 
unrelated healthy German individuals. Plasma was obtained by centrif- 
ugation and leucocyte DNA was isolated as described by Miller et al. 
[18]. In selected cases (heterozygous genotype) blood samples were also 
collected from family members. Plasma samples from three individuals 
with a homozygous CS/I deficiency were kindly provided by Dr. W. 
Niirnberger. 
2.2 Polymerase chain reaction (PCR) 
The PCR was performed using the following primers: C8B-63-F 
(Y-GCTCCAGCCCTCTCAGTTC-3’) corresponding to positions 
129-147 of the C8/3 cDNA sequence reported by Haefliger et al. [16] 
and C8B-63-R (Y-AAAGCCTTCACATCGCACTT-3’) complemen- 
tary to positions 237-218. Standard PCR was carried out in a 50 ~1 
volume containing 80 ng genomic template, 20 pmol of each primer, 200 
uM of each deoxvnucleotide triohosphate (dATP, dCTP, dGTP, 
hTTP), 50 mM KCl: 10 mM Tris-H-Cl (pH 8.3);l.S mM MgCl,, 0.01% 
gelatine and 2.5 U Taq-Polymerase (Perkin-Elmer Cetus). Samples 
were processed in a Perkin-Elmer Cetus DNA Thermal Cycler through 
30 temperature cycles consisting of 30 s at 94°C 30 s at 55”C, and 30 s 
at 72°C followed by a final extension step of 10 min at 72°C. An 
aliquot (IO ~1) of the PCR product was digested using 5 U/sample of 
AciI (New England Bio Labs) according to the manufacturer’s instruc- 
tions. Fragments were separated on 10% polyacrylamide gels and visu- 
alized by silver-staining [19]. 
2 3. Cloning and sequencing of PCR products 
PCR products from two heterozygous individuals were cloned into 
pUC 18 SmaIIBAP vector (Pharmacia). Lysates from single colonies 
were used as template for PCR with primer pair C8B-63-F/C8B-63-R; 
subsequent AciI digestion of the PCR product allowed the identifica- 
tion of clones containing different alleles. From selected colonies a 
hemibiotinylated PCR product was generated by using one biotinylated 
vector primer and one normal vector primer. The PCR product was 
incubated with streptavidine Dynabeads (Dynal Ltd.) and magnetic 
beads were collected with a magnetic oncentrator. After washing and 
denaturing both strands of DNA were sequenced using Sequenase 
Version 2.0 Kit (US Biochemicals). 
2.4, Analvsis of the CSg protein polymorphism 
CS/l protein phenotypes were determined by methods comparable to 
those previously used for C7 typing [20,21]. Prior to focusing, all plasma 
samples were pretreated with Clostridum perfringens neuraminidase 
(Sigma, type V). 15 ~1 of the enzyme solution (30 U/ml 1 M potassium 
phosphate buffer, pH 7.0) were added to 90~1 plasma; the mixture was 
incubated overnight at room temperature. The desialized samples 
(25~1) were subjected to IEF in thin-layer polyacrylamide gels 
(110 x 240 x 0.8 mm) containing 2.8% (w/v) Ampholine carrier ampho- 
lytes (LKBIPharmacia; pH 3.5510, pH 5-8, pH 7-9. pH 8-9.5 (3:2:3:2)) 
and, according to Alper et al. [9]. 3 M urea. IEF along the short axis 
of the gel was carried out for 5% h. Including 30 min prefocusing; the 
settings for the power supply were 1400 V. 40 mA and 13 W. The 
focused proteins were transferred onto a nitrocellulose membrane (0.45 
pm; Schleicher and Schuell BA-85) by press-blotting for 1 h [20]. After 
protein transfer the nitrocellulose was removed from the gel, blocked 
overnight at 4°C in phosphate-buffered saline (PBS; pH 7.2) containing 
3% (w/v) bovine serum albumine (BSA; Sigma, fraction V) and then 
washed 3 x 5 min in PBS. A goat anti-human-C8 antiserum (Cappel) 
and a peroxidase-conjugated rabbit anti-goat-immunoglobuhn a tise- 
rum (DAKO) were used for the subsequent enzyme immunoassay. The 
nitrocellulose membrane was probed for 120 min at 37’C with the first 
antibody (diluted I:200 in 3% BSA/PBS), washed 5 x 5 mm in PBS. 
exposed to the second antibody (diluted 1:500 in 3% BSAIPBS) for 120 
mm at 37°C and washed again 5 x 5 min in PBS. Finally, peroxidase 
activity was developed using o-diamsidine [21]. CS/I phenotypes were 
scored without knowledge of genotyping results. 
3. Results 
To evaluate if codon 63 of the human C8B gene is 
indeed polymorphic, as suggested by the difference be- 
tween the two published C8/? cDNA sequences [16,17], 
we used PCR to amplify a 109-base pair (bp) segment of 
the C8B gene containing the putatively polymorphic site. 
Primers were designed from the CSj? cDNA sequence 
assuming homology of the C8B gene structure with the 
known exon-intron organization of complement C9 
gene [22]. Amplification of genomic DNA resulted in a 
single DNA fragment of the expected size. The sequence 
difference noted in the cDNA sequences i  distinguisha- 
ble by a change in a recognition site for restriction endo- 
nuclease AciI. As can be seen from Fig. 1, digestion of 
the 109-bp PCR product with AciI resulted in a restric- 
tion fragment length polymorphism (RFLP), depending 
on the absence or presence of the polymorphic AciI re- 
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Fig. 1. Restriction fragment length polymorphism of complement C8B 
gene as detected by AcrI digestion of a 109-bp PCR product encompass- 
ing codons 35571. Lanes 1 and 2, genotype C8B*I/CBB*2; lanes 3 to 
7, genotype C%‘B*Z/C8B*I; lane 8, molecular weight marker (@X174 
DNA-HaeIII digest). 
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Fig. 2. Autoradiograms of the regions of sequencing els showing the 
single nucleotide substitution (A -+ G) that determines the presence of 
either Arg or Gly at position 63 of the mature C8jI chain. Sequence 
analysis of both alleles from an individual with genotype C8B*lIC8B*2 
(and protein phenotype C8B AB). 
striction site, either a fragment of 109 bp (allele C8B*1) 
or two fragments of 81 bp and 28 bp (allele C8B*2) are 
produced. Autosomal codominant inheritance of alleles 
was demonstrated in four two-generation families each 
with at least two children. The existence of a nucleotide 
sequence variation in codon 63 was confirmed by se- 
quencing both alleles from genotypically heterozygous 
individuals (Fig. 2). The polymorphism changes codon 
63 from AGA (encoding Arg; AciI site absent) to GGA 
(encoding Gly; AciI site present). Typing 82 unrelated 
German Caucasians we observed 74 individuals ho- 
mozygous for C8B*Z and 8 individuals with the 
heterozygous C8B*l/C8B*2 genotype. The allele fre- 
quencies were 0.951 (C8B*Z) and 0.049 (C8B*2). 
To investigate the relationship between the AciI RFLP 
and CS/I protein polymorphism plasma samples from the 
82 unrelated genotyped German individuals were sub- 
jected to isoelectric focusing in polyacrylamide gels con- 
taining 3 M urea and C8 protein bands were identified 
by immunoblotting. IEF in the presence of urea causes 
dissociation of C8 into a-y and /I, thus facilitating the 
separate analysis of a-y- and /?-subunits [9]. The IEF 
conditions employed in the present study allowed an 
unequivocal typing of C8/? phenotypes (Fig. 3). C8/3 
bands are located in the more cathodal region of the gel. 
The specificity of the detection system is clearly sup- 
ported by the observation that plasma samples from in- 
dividuals with a genetically determined homozygous C8/? 
deficiency did not show any bands in this region. In 
accordance with observations of other authors [ 11,12,15] 
we also encountered immunoreactive patterns (originat- 
ing from the a-y-subunit) in the more anodal region of 
the gel; however, the IEF conditions used here for /?- 
chain typing did not allow a clear typing of the a-y- 
pattern. As can be seen in Fig. 3, two different structural 
C8j5 phenotypes were observed: C8B B and C8B AB. 
There was an absolute concordance between CS/I protein 
typing and DNA typing. All 74 individuals with geno- 
type C8B*lIC8B*I (Arg631Arg63) were typed as C8B B. 
The 8 individuals with heterozygous C8B*lIC8B*2 gen- 
otype (Arg63/Gly63) were all C8B AB. 
4. Discussion 
In the present study we describe a sequence polymor- 
phism in codon 63 of the C8B gene. Allele C8B*Z is 
characterized by the nucleotide sequence AGA coding 
for an arginine residue, allele C8B*2 by the nucleotide 
sequence GGA coding for a glycine residue. This varia- 
tion is easily detected as an RFLP after AciI digestion of 
an amplified 109-bp portion of the C8B gene. During the 
preparation of this manuscript, the exon-intron organi- 
zation of the C8B gene has been reported, demonstrating 
that it is indeed highly homologous to the structure of 
the C9 gene [23]. The nucleotide sequence amplified with 
our primers C8B-63-F and C8B-63-R is completely lo- 
cated within exon 3 of the C8B gene. 
The method described here for C8g protein typing 
allows an unequivocal identification of phenotypes; it 
will be valuable for further population screening and in 
particular for the identification of rare electromorphs. 
The separate analysis of the B-chain polymorphism, pos- 
sible due to IEF in the presence of urea [9], is easier than 
the typing of banding patterns produced by complete C8 
molecules (IEF in the absence of urea) [11,12] where 
pattern variation reflects the genetic variability of both 
the a-y- and the B-subunit of C8. The allele frequencies 
that we encountered in 82 unrelated German individuals 
are in excellent agreement with frequencies previously 
reported for U.S. Whites and Norwegians [9,11]. 
Investigating DNA and plasma samples from 82 unre- 
1 2 3 4 5 6 
Fig. 3. C8jl protein phenotypes observed in the present study. Lanes 1 
and 6, C8B AB; lanes 2, 4 and 5, C8B B; lane 3, sample from an 
individual with homozygous C8b deficiency. In the heterozygous pat- 
tern the A band is consistently stronger than the B band. 
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lated individuals we observed absolute concordance be- 
tween the AciI RFLP and C8g protein polymorphism. 
We thus conclude that the C8B B allotype is character- 
ized by an arginine residue and the C8B A allotype by 
a glycine residue at position 63 of the C8g polypeptide 
chain. With regard to IEF the incorporation of an elec- 
trically neutral residue (Gly) in C8B A, substituting the 
positively charged Arg residue of C8B B, is expected to 
cause a shift towards the anode. Thus, this substitution 
might well explain the difference between C8B B and 
C8B A observed in IEF gels. Aligning the two published 
C8p cDNA sequences reveals that the A+G substitu- 
tion in the first position of codon 63 is the only difference 
within the whole coding sequence. In this context it 
seems important that both groups obtained the complete 
coding sequence from a single full-length cDNA clone, 
i.e. the cDNA sequence was not compiled from smaller 
overlapping clones. Therefore, it seems most likely that 
the two sequences are in fact cDNA sequences of two 
different alleles, namely C8B*I and C8B*2, and that 
these two alleles differ exclusively in the first position of 
codon 63, at least with regard to the coding sequence. In 
the present study we demonstrated that the substitution 
in codon 63 consistently differentiates between C8B B 
and C8B A. Taking together, we propose that the Arg/ 
Gly polymorphism in codon 63 is the molecular basis of 
the C8B B/C8B A protein polymorphism. 
of complement activation, and in cell surface antigens of 
malaria parasites [29, 31 and references therein]. On the 
basis of different Cys residue locations and different TSR 
lengths, Smith et al. [32] have subdivided TSR sequences 
into three groups. Group 1 includes mainly the sequences 
found in thrombospondin and properdin; group 2 corre- 
sponds to the N-terminal and group 3 to the C-terminal 
TSRs of the late complement components. The precise 
role of TSRs is not known but could well involve 
protein-protein or protein-phospholipid interactions 
[26,27,29]. Interestingly, it has recently been shown that 
the common A/B polymorphism of complement compo- 
nent C6 is also due to a charged amino acid substitution 
in the group 2 TSR of the protein [33,34]. Detailed stud- 
ies of the structure-function relationships of the terminal 
complement components will be important to define the 
interactions between these proteins at the molecular level 
and to elucidate the eventual functional significance of 
polymorphic variation within certain domains. 
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